Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Gene Therapy

Recent news which mentions Gene Therapy

< Previous 1 2 3 Next >
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
Tickers AGTC
Tags News Phase 2 Trial Biotech
From Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Benzinga Health Care Market News
From Benzinga
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
Tickers PFE
Tags gene therapy Briefs News
From Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
Tickers OCGN
Tags Penny Stocks gene therapy Briefs
From Benzinga
Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
Tags cell therapy gene therapy Biotechnology
From PRUnderground
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
Tickers FOLD
Tags Market News Benzinga FOLD
From Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags NTLA BLUE Health Care
From Benzinga
Why Bluebird Bio Shares Are Tumbling Today
Tickers BLUE
Tags gene therapy Penny Stocks Biotech
From Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
Tickers ARYD FOLD
Tags Guidance Movers General
From Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
Tickers TAK TKPHF
Tags Benzinga TKPHF Market News
From Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
Tickers BMRN
Tags BMRN gene therapy Briefs
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags RGNX Biotech Phase 2 Trial
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags AVRO Benzinga Market News
From Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
Tickers SGMO
Tags SGMO Benzinga Market News
From Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
Tickers SIOX
Tags General Market News Management
From Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
Tickers TSHA
Tags Benzinga Health Care Market News
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags gene therapy Briefs Phase 1 Trial
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags News Phase 2 Trial Biotech
From Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
Tickers BLUE
Tags Market News Benzinga FDA
From Benzinga
Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
Tickers SRPT
Tags SRPT Benzinga Health Care
From Benzinga
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
Tickers BLUE
Tags Market News why it's moving Benzinga
From Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
Tickers BMRN
Tags News Hemophilia A General
From Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
Tickers PFE
Tags Health Care Biotech News
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Benzinga Market News General
From Benzinga
Why Are Bluebird Bio Shares Trading Lower Today?
Tickers BLUE
Tags General Movers FDA
From Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
Tickers BLUE
Tags Health Care BLUE News
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
Tickers QURE
Tags Health Care Briefs gene therapy
From Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Tickers BLUE
Tags Benzinga Market News Small Cap
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags Phase 2 Trial News Biotech
From Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
Tickers SELB
Tags Phase 2 Trial SELB News
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.